Fundraising Fox
Innorna
1 known investors
Find your way into Innorna
Sign up to find every way you can get introduced to Innorna
- Your email: who you already know at Innorna, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Innorna team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BApr 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Innorna do?
- Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.
- Who are Innorna's investors?
- Innorna's investors include Blue Ocean Capital Group.